Active Stocks
Wed May 29 2024 11:43:23
  1. State Bank Of India share price
  2. 826.30 -0.55%
  1. HDFC Bank share price
  2. 1,509.25 -1.39%
  1. Tata Steel share price
  2. 173.65 -0.69%
  1. Power Grid Corporation Of India share price
  2. 315.90 0.99%
  1. ITC share price
  2. 428.35 -0.13%
Business News/Market/Market Stats/    Tata India Pharma & Healthcare Fund Regular Growth

Tata India Pharma & Healthcare Fund Regular Growth

+
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
25.58 +0.12 (0.49%) NAV as on 28 May, 2024
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)893.64
  • CAGR 51.76%
  • Exit Load0.25%
  • Expense ratio2.25%
  • CategoryEquity
  • Min Investment5000
  • Min SIP100
  • Launch Date2015-12-28

Morning Star Rating N.A.

Medium
Risk
Exceptional
Return

Asset Allocation

Holdings As On - 29 May 2024

  • Name
  • Value (Cr)
  • Holding %
View More

Risk & Volitility

  • Alpha 11.23%
  • Beta 0.70
  • Sharpe Ratio0.76
  • Std Deviation 14.24%
  • Tracking Error 10.07%

About Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

 

The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 893.64 crores & has delivered CAGR of 23.97% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 2.25%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Aurobindo Pharma, Lupin & Dr Reddys Laboratories.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

 

Some of the similar funds are Tata India Pharma & Healthcare Fund Regular Growth, Mirae Asset Healthcare Fund Regular Growth, UTI Healthcare Fund Regular Plan Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.76 & a standard deviation of 14.24%.

FAQs about Tata India Pharma & Healthcare Fund Regular Growth

According to the morning star rating Tata India Pharma & Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
Tata India Pharma & Healthcare Fund Regular Growth is managed by Meeta Shetty.
The expense ratio of Tata India Pharma & Healthcare Fund Regular Growth is 2.25%.
The 5 year annualized return on Tata India Pharma & Healthcare Fund Regular Growth is 23.97% & it has generated 51.76% in the last 1 year.
The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is 5000 Rs.
Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 893.64 crores.
Recommended For You